Edition:
United Kingdom

Straumann Holding AG (STMN.S)

STMN.S on Swiss Exchange

632.00CHF
4:00pm GMT
Change (% chg)

CHF10.00 (+1.61%)
Prev Close
CHF622.00
Open
CHF630.00
Day's High
CHF640.50
Day's Low
CHF623.50
Volume
35,255
Avg. Vol
43,098
52-wk High
CHF814.00
52-wk Low
CHF581.00

Chart for

About

Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and... (more)

Overall

Beta: 0.74
Market Cap(Mil.): CHF10,241.94
Shares Outstanding(Mil.): 15.88
Dividend: 4.25
Yield (%): 0.66

Financials

  STMN.S Industry Sector
P/E (TTM): 42.60 32.18 33.63
EPS (TTM): 15.14 -- --
ROI: 23.11 13.76 15.02
ROE: 34.09 16.50 16.60

Dental implant maker Straumann ups full year guidance

ZURICH, Oct 30 Dental implant maker Straumann Holding raised its full year sales outlook on Tuesday, saying new products and its wider market presence would mean faster growth this year.

30 Oct 2018

BRIEF-Straumann To Gain Control Of Taiwan's T-Plus

* GROUP TO GAIN CONTROL OF T-PLUS, AN ESTABLISHED TAIWANESE MANUFACTURER OF ATTRACTIVELY-PRICED IMPLANT SYSTEMS

19 Sep 2018

BRIEF-Straumann: Peter Zihla Joins Executive Management Team As New Head Of Digital Business Unit

* PETER ZIHLA JOINS STRAUMANN'S EXECUTIVE MANAGEMENT TEAM AS NEW HEAD OF DIGITAL BUSINESS UNIT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

23 Aug 2018

BRIEF-Straumann H1 EBITDA Increased 29% To CHF 203 Mln

* FIRST-HALF REVENUE SURGES 25% IN SWISS FRANCS (18% ORGANIC) TO CHF 682 MILLION

14 Aug 2018

BRIEF-Straumann Holding Acquires 30% Stake In Botiss

* ACQUIRED A 30% STAKE IN ITS BIOMATERIALS PARTNER BOTISS MEDICAL AG FOR AN UNDISCLOSED SUM Source text for Eikon: Further company coverage: (Gdynia Newsroom)

04 Jul 2018

Earnings vs. Estimates